XORTX Therapeutics Inc. filed a Form 6-K report on October 24, 2024, indicating its compliance with SEC rules. This event is categorized under 'Changes in management or control' as it involves a signature from the CEO.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.